Not logged in.png)
Share.png)
SaveGenetic and immune landscape evolution in MMR-deficient colorectal cancer
Challoner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Fong, Caroline; Barber, Louise J.; Anandappa, Gayathri; Crux, Richard; Assiotis, Ioannis; Fenwick, Kerry; Begum, Ruwaida; Begum, Dipa; Lund, Tom; Sivamanoharan, Nanna; Sansano, Harold B.; Domingo-Arada, Melissa; Tran, Amina; Pandha, Hardev; Church, David; Eccles, Bryony; Ellis, Richard; Falk, Stephen; Hill, Mark; Krell, Daniel; Murugaesu, Nirupa; Nolan, Luke; Potter, Vanessa; Saunders, Mark; Shiu, Kai-Keen; Guettler, Sebastian; Alexander, James L.; Lazare-Iglesias, Hector; Kinross, James; Murphy, Jamie; von Loga, Katharina; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancerChalloner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Barber, Louise J.; Lund, Tom; Sansano, Harold B.; von Loga, Katharina; Lazare-Iglesias, Hector; Begum, Ruwaida; Crux, Richard; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancerChalloner, Benjamin R.; Woolston, Andrew; Lau, David; Buzzetti, Marta; Barber, Louise J.; Lund, Tom; Sansano, Harold B.; von Loga, Katharina; Lazare-Iglesias, Hector; Begum, Ruwaida; Crux, Richard; Cunningham, David; Chau, Ian; Starling, Naureen; Ruiz-Banobre, Juan; Dhillon, Tony; Gerlinger, Marco Share Save PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinomaPinato, David J.; Cortellini, Alessio; Sukumaran, Ajithkumar; Cole, Tom; Pai, Madhava; Habib, Nagy; Spalding, Duncan; Sodergren, Mikael H.; Martinez, Maria; Dhillon, Tony; Tait, Paul; Thomas, Robert; Ward, Caroline; Kocher, Hemant; Yip, Vincent; Slater, Sarah; Sharma, Rohini Share Save Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyLau, David; Kalaitzaki, Eleftheria; Church, David N.; Pandha, Hardev; Tomlinson, Ian; Annels, Nicola; Gerlinger, Marco; Sclafani, Francesco; Smith, Gillian; Begum, Ruwaida; Crux, Richard; Gillbanks, Angela; Wordsworth, Sarah; Chau, Ian; Starling, Naureen; Cunningham, David; Dhillon, Tony Share Save AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001Marinov, Marin; Ziogas, Algirclas; Pardo, Olivier E.; Tan, Liwen Terence; Dhillon, Tony; Mauri, Francesco A.; Lane, Heidi A.; Lemoine, Nicholas R.; Zangemeister-Wittke, Uwe; Seckl, Michael J.; Arcaro, Alexandre Share Save Share Save A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapyBower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; Young, AM; Powles, T; Gaya, A; Nelson, M; Stebbing, J Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
